Clinical trial NCT06171425: Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty
Official title: Diffüz Parankimal Akciğer Hastalarında Kırılganlık Düzeyi, Egzersiz Kapasitesi ve Denge Değerlendirilmesi
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Diffuse Parenchymal Lung Disease
Frailty
Physical Inactivity
Lead sponsor: Hacettepe University
Sponsor class: OTHER
First posted: 2023-12-14
Enrollment: 28
Sex: ALL
Minimum age (years): 30
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients referred by the department of chest diseases of Hacettepe university will be taken

Brief summary: There are very few studies in the literature examining the frailty levels of diffuse parenchymal lung disease (DPLD) patients and its effect on their functional status despite the high prevalance of frailty in patients with DPLD This observational study aims to learn about the relationship between frailty and functional capacity and balance in DPLD patients compared to healthy subjects.

Detailed description: The aim of the study is to evaluate the relationship between the level of frailty and exercise capacity, respiratory functions, diffusion capacity, balance level, postural changes, activities of daily living, peripheral muscle strength and quality of life parameters in DPLD patients. The second aim is to compare diffuse parenchymal lung patients and the healthy control group in terms of these parameters.

Eligibility criteria: Inclusion Criteria:

* Being diagnosed with Diffuse parenchymal lung according to the American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,
* Being between the ages of 30-65,
* Being literate,
* Being willing to participate in the research,
* Being clinically stable and having any accompanying comorbid conditions (such as hypertension, diabetes) under control,
* Not having any orthopedic, metabolic or neurological problems that may prevent evaluation of peripheral muscle strength, balance and exercise capacity.

Exclusion Criteria:

* Having recently experienced syncope,
* Having a history of unstable cardiovascular disease,
* Having been hospitalized due to exacerbation in the last 3 months,
* Having received pulmonary rehabilitation in the last 12 months,
* Having a neurological disease,
* Being dependent and using a walking aid while performing the person's daily life activities,
* Having a pacemaker,
* Having a diagnosis of lung cancer

Primary outcomes:
measure: frailty level
timeFrame: 1 time which will be in one day
Secondary outcomes:
measure: comorbidity assesment
timeFrame: 1 time which will be in one day
measure: exercise capacity
timeFrame: 1 time which will be in one day
measure: balance measurement
timeFrame: day 1
measure: posture analysis
timeFrame: day 1
measure: posture related conditions measurement
timeFrame: day 1
measure: posture related (scapular motion)conditions existence measurement
timeFrame: day 1
measure: quality of life evaluation
timeFrame: day 1
measure: evaluation of participation to daily life activities
timeFrame: day 1
measure: pulmonary function measurement
timeFrame: day 1
measure: investigation of diffusion capacity of the lung
timeFrame: day 1
measure: peripheral muscle strength
timeFrame: day 1
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Hacettepe University, Health Sciences Faculty
Study officials:
References: